The CenterWatch Monthly, January 2016
Monday, January 4, 2016
New insights for better patient engagement
In the largest and most in-depth global survey of its kind, the Center for Information and Study on Clinical Research Participation (CISCRP) found the public has a high level of willingness to participate in clinical research, yet the industry lacks the ability to translate that support into clinical trial participation. In addition, the disconnect between the stated willingness to participate in clinical research and low participation rates was more pronounced in certain subgroups, including minority communities and patients with mild-to-moderate diseases.
A look at the evolving role of study brokers
For many small to medium-sized investigative sites, the scramble to find clinical study opportunities continues to intensify. Some sites have become part of informal networks that help find available studies for individual members, while others turn to middlemen or trial management firms, often called study brokers, who are available to assist investigative sites in boosting their business development and lead-generation efforts. While study brokers have been in operation for more than two decades, their business model has changed substantially from simply finding studies and charging hefty up-front fees to offering a wide range of support services including forecasting and budgeting, centralized study start-up assistance, media buying and recruitment promotion, lead generation and business development, general marketing and operations consulting.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.